Title: ACI-24, an anti-beta amyloid vaccine, in patients with mild Alzheimer’s disease: Results of a phase 2, randomized, double-blind, placebo-controlled study Presenter: Poster P44 presented ...
The ALZpath proprietary pTau 217 antibody was recognized in the medical care category for its ability to accurately diagnose Alzheimer's disease. ALZpath Proprietary pTau217 Antibody Named to TIME ...